Back
Metagenomi 10K Form
Sell
48
MGX
Metagenomi
Last Price:
$2.13
Seasonality Move:
-50.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MGX News And Ratings
See the #1 stock for the next 7 days that we like better than MGX
MGX Financial Statistics
Sales & Book Value
Annual Sales: | $52.3M |
---|---|
Cash Flow: | $-23.1M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.69 |
Price / Book: | 0.37 |
Profitability
EPS (TTM): | -2.11000 |
---|---|
Net Income (TTM): | $-77.9M |
Gross Margin: | -- |
Return on Equity: | -31.22% |
Return on Assets: | -21.87% |
Metagenomi Earnings Forecast
Key Metagenomi Financial Ratios
-
The Research & Development expenses have been 208.78% of Revenue.
-
The Net Earning history of MGX is -149.26% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 0 years.
Metagenomi Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | MGX |
Website: | metagenomi.co |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.85 |
Quick Ratio: | 5.69 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
MGX Technical Analysis vs Fundamental Analysis
Sell
48
Metagenomi (MGX)
is a Sell
Is Metagenomi a Buy or a Sell?
-
Metagenomi stock is rated a SellThe current Metagenomi [MGX] share price is $2.10. The Score for MGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.